Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Long-term study of KRP-114V in overactive bladder
jRCT2080222748Phase 3
- Sponsor
- Kyorin Pharmaceutical
- Start
- Feb 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, open-label, single-arm trial of vibegron in overactive bladder (OAB), sponsored by Kyorin Pharmaceutical.
02
Drugs
vibegron
03
Conditions
overactive bladder (OAB)
Beyond the preview
Go deeper on jRCT2080222748.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2080222748.